with UltranodeX hitting 800 cycles @ 80% capacity retention, has more implications than just with partner requirements.
from 14 months ago.
definitely not a one for one $ grant requirement. and we have purchased equipment and upgraded facilities, with production, battery design and testing capabilities.
$1.39m would ease the $ demands for the next quarter
also jogged my memory of this from last year when reading the quarterly
I have posted about SIOI's vaccines in development and approval process. "incorporation of anteobind into a vaccine manufacturing process" reads totally different from just a QC process. Hmmmm !!!!!
GLTAH
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $27.05M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.8¢ | $64.70K | 6.680M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1988556 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 405002 | 3 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| ADO (ASX) Chart |